Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...
“To more accurately stage disease and track progression over time ... and confirmatory testing for the amyloid pathology is ...
An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage ...
Midland Reporter-Telegram on MSN
Craddick backs proposition to fund $3B dementia research institute
Rep. Tom Craddick and the Alzheimer’s Association urge voters to back Texas Proposition 14, creating DPRIT with $3B for ...
A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...
This represents Alector's second failed neurodegenerative asset in a year, after an AbbVie-partnered asset missed in ...
The Elecsys pTau181 blood test has been cleared to help rule out Alzheimer’s disease. The test correctly identified people ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback